Market Performance
The stock market today witnessed a strong debut from Anondita Medicare, as the company’s shares opened with a sharp listing gain on the NSE SME platform. The Anondita Medicare share price listed at ₹275.50 on September 1, marking a 90% premium over its IPO issue price of ₹145.
The robust listing immediately caught investor attention, adding to the upbeat sentiment in the broader SME market.
Main News
The highlight of the day was the successful listing of Anondita Medicare, which became one of the most talked-about SME IPOs in recent times. The company had already set the tone during its bidding phase, drawing massive interest across investor categories.
Key highlights from the IPO subscription phase:
- Overall Subscription: 300.89 times
- Retail Investors: 286.20 times
- Qualified Institutional Buyers (QIBs): 153.03 times
- Non-Institutional Investors (NIIs): 531.82 times
In total, the SME IPO received bids for 95.47 crore shares against just 31.73 lakh shares on offer.
Anondita Medicare IPO Details
The company launched a fresh issue of shares worth ₹69.50 crore, entirely through a new share sale of 0.48 crore shares.
Key details of the issue:
- Price Band: ₹137 – ₹145 per share
- Subscription Window: August 22 – August 26, 2025
- Allotment Finalised: August 28, 2025
- Listing Date: September 1, 2025
For retail investors, the minimum application size was 1,000 shares per lot, with a requirement of at least two lots. This meant an investment of ₹2,90,000 was needed to participate.
The funds raised are earmarked for:
- Purchasing equipment and machinery
- Meeting working capital requirements
- Supporting acquisition plans
- General corporate purposes
Company Details
Founded in 2024, Anondita Medicare operates in the healthcare and consumer products space. Its primary business is the manufacturing of flavoured male condoms, marketed under the flagship brand “COBRA.”
Key operational highlights:
- Annual Production Capacity: 562 million condoms
- Manufacturing Facility: Noida, Uttar Pradesh
The company positions itself as a significant player in the contraceptive products market, catering to both domestic demand and international supply chains.
Summary
The Anondita Medicare share price debut on NSE SME at ₹275.50, almost double its issue price, reflects the strong appetite for SME IPOs in the stock market today. With oversubscription figures crossing 300 times, the IPO was a clear success story.
By raising ₹69.50 crore, the company aims to strengthen its operations and expand capacity, setting a strong foundation for its future growth.
Easy & quick
Leave A Comment?